Metabolic Dysregulation and Cancer Risk Program (MeDOC): a transdisciplinary approach to obesity-associated cancers.

Area of Science:

• Oncology
• Metabolic Science
• Public Health

Background:

• Obesity is a significant and growing public health concern linked to increased cancer risk.
• Obesity-driven mechanisms like metabolic changes, chronic inflammation, and insulin resistance are implicated in cancer development.
• The precise biological mechanisms connecting obesity and cancer remain largely unknown.

Purpose of the Study:

• To advance understanding of the mechanisms linking obesity, metabolic dysregulation, and cancer risk.
• To identify biomarkers for improved cancer risk prediction and screening in high-risk individuals.
• To discover therapeutic targets for cancer interception and treatment.

Main Methods:

• The Metabolic Dysregulation and Cancer Risk (MeDOC) Program is a transdisciplinary research initiative.
• Funded research projects investigate obesity-associated cancers.
• A Coordinating Center supports the program's research efforts.

Main Results:

• The MeDOC program supports diverse research projects exploring obesity-cancer links.
• The program facilitates a coordinated, transdisciplinary approach to a complex health issue.
• Specific research findings will be detailed in subsequent reports from funded projects.

Conclusions:

• Understanding obesity-cancer mechanisms is crucial for public health.
• The MeDOC program is poised to yield significant insights into obesity-related cancer.
• This initiative aims to translate research into improved cancer prevention and treatment strategies.